117 related articles for article (PubMed ID: 32962622)
1. Bronchospasmolytic and Adenosine Binding Activity of 8- (Proline / Pyrazole)- Substituted Xanthine Derivatives.
Singh S; Ojha M; Yadav D; Kachler S; Klotz KN; Yadav R
Curr Drug Discov Technol; 2021; 18(5):e22092020186181. PubMed ID: 32962622
[TBL] [Abstract][Full Text] [Related]
2. Bronchospasmolytic activity and adenosine receptor binding of some newer 1,3-dipropyl-8-phenyl substituted xanthine derivatives.
Gumber D; Yadav D; Yadav R; Kachler S; Klotz KN
Chem Biol Drug Des; 2020 Jun; 95(6):600-609. PubMed ID: 32100461
[TBL] [Abstract][Full Text] [Related]
3. Novel 8-(p-substituted-phenyl/benzyl)xanthines with selectivity for the A2A adenosine receptor possess bronchospasmolytic activity.
Yadav R; Bansal R; Kachler S; Klotz KN
Eur J Med Chem; 2014 Mar; 75():327-35. PubMed ID: 24556147
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological characterization of novel xanthine carboxylate amides as A2A adenosine receptor ligands exhibiting bronchospasmolytic activity.
Yadav R; Bansal R; Rohilla S; Kachler S; Klotz KN
Bioorg Chem; 2016 Apr; 65():26-37. PubMed ID: 26851736
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of new 8-heterocyclic xanthine derivatives as highly potent and selective human A2B adenosine receptor antagonists.
Baraldi PG; Tabrizi MA; Preti D; Bovero A; Romagnoli R; Fruttarolo F; Zaid NA; Moorman AR; Varani K; Gessi S; Merighi S; Borea PA
J Med Chem; 2004 Mar; 47(6):1434-47. PubMed ID: 14998332
[TBL] [Abstract][Full Text] [Related]
6. Novel 1,3-disubstituted 8-(1-benzyl-1H-pyrazol-4-yl) xanthines: high affinity and selective A2B adenosine receptor antagonists.
Kalla RV; Elzein E; Perry T; Li X; Palle V; Varkhedkar V; Gimbel A; Maa T; Zeng D; Zablocki J
J Med Chem; 2006 Jun; 49(12):3682-92. PubMed ID: 16759111
[TBL] [Abstract][Full Text] [Related]
7. 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists.
Hayallah AM; Sandoval-Ramírez J; Reith U; Schobert U; Preiss B; Schumacher B; Daly JW; Müller CE
J Med Chem; 2002 Mar; 45(7):1500-10. PubMed ID: 11906291
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A
Harmse R; van der Walt MM; Petzer JP; Terre'Blanche G
Bioorg Med Chem Lett; 2016 Dec; 26(24):5951-5955. PubMed ID: 27836398
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships in a series of 8-substituted xanthines as bronchodilator and A1-adenosine receptor antagonists.
Corsano S; Strappaghetti G; Scapicchi R; Lucacchini A; Senatore G
Arch Pharm (Weinheim); 1995 Sep; 328(9):654-8. PubMed ID: 7487422
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of a New Series of 8-(2-Nitroaryl)Xanthines as Adenosine Receptor Ligands.
Bansal R; Kumar G; Rohilla S; Klotz KN; Kachler S; Young LC; Harvey AL
Drug Dev Res; 2016 Aug; 77(5):241-50. PubMed ID: 27404511
[TBL] [Abstract][Full Text] [Related]
11. The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines.
Van der Walt MM; Terre'Blanche G; Petzer A; Lourens AC; Petzer JP
Bioorg Chem; 2013 Aug; 49():49-58. PubMed ID: 23892098
[TBL] [Abstract][Full Text] [Related]
12. 7-Substituted 5-amino-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidines as A2A adenosine receptor antagonists: a study on the importance of modifications at the side chain on the activity and solubility.
Baraldi PG; Cacciari B; Romagnoli R; Spalluto G; Monopoli A; Ongini E; Varani K; Borea PA
J Med Chem; 2002 Jan; 45(1):115-26. PubMed ID: 11754583
[TBL] [Abstract][Full Text] [Related]
13. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells.
Klotz KN; Hessling J; Hegler J; Owman C; Kull B; Fredholm BB; Lohse MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jan; 357(1):1-9. PubMed ID: 9459566
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and preliminary evaluation of new 1- and 3-[1-(2-hydroxy-3-phenoxypropyl)]xanthines from 2-amino-2-oxazolines as potential A1 and A2A adenosine receptor antagonists.
Massip S; Guillon J; Bertarelli D; Bosc JJ; Léger JM; Lacher S; Bontemps C; Dupont T; Müller CE; Jarry C
Bioorg Med Chem; 2006 Apr; 14(8):2697-719. PubMed ID: 16386423
[TBL] [Abstract][Full Text] [Related]
15. De novo analysis of receptor binding affinity data of 8-ethenyl-xanthine antagonists to adenosine A1 and A2a receptors.
Dalpiaz A; Gessi S; Varani K; Borea PA
Arzneimittelforschung; 1997 May; 47(5):591-4. PubMed ID: 9205770
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships in a series of 8-substituted xanthines as A1-adenosine receptor antagonists.
Strappaghetti G; Corsano S; Barbaro R; Giannaccini G; Betti L
Bioorg Med Chem; 2001 Mar; 9(3):575-83. PubMed ID: 11310591
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of 3,7-dimethyl-1-propargylxanthine derivatives, A2A-selective adenosine receptor antagonists.
Müller CE; Geis U; Hipp J; Schobert U; Frobenius W; Pawłowski M; Suzuki F; Sandoval-Ramírez J
J Med Chem; 1997 Dec; 40(26):4396-405. PubMed ID: 9435909
[TBL] [Abstract][Full Text] [Related]
18. Bronchodilator activity of xanthine derivatives substituted with functional groups at the 1- or 7-position.
Miyamoto K; Yamamoto Y; Kurita M; Sakai R; Konno K; Sanae F; Ohshima T; Takagi K; Hasegawa T; Iwasaki N
J Med Chem; 1993 May; 36(10):1380-6. PubMed ID: 8496906
[TBL] [Abstract][Full Text] [Related]
19. 1,3,7-Triethyl-substituted xanthines--possess nanomolar affinity for the adenosine A1 receptor.
Van der Walt MM; Terre'Blanche G
Bioorg Med Chem; 2015 Oct; 23(20):6641-9. PubMed ID: 26392370
[TBL] [Abstract][Full Text] [Related]
20. A New Series of 1,3-Dimethylxanthine Based Adenosine A
Rohilla S; Bansal R; Chauhan P; Kachler S; Klotz KN
Curr Drug Discov Technol; 2021; 18(5):e26082020185360. PubMed ID: 32860362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
